DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / M•••••••• C•••••• A•••••••• L•••
M•••••••• C•••••• A•••••••• L•••
Institutional venture firmUSm••••••••.bioSEC venture capital fund adviserone firm, 2 filing advisers
This firm files as 2 advisers on m••••••••.bio: M•••••••• C•••••• A••••••• •••• L••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $219M across 2 vehicles
Importance
27
moderate
Active deployment
33
moderate
Emerging
0
low
Completeness
63
high
Freshness
98
high
Research priority
13
low
Identity and regulatory footprint
- Headquarters
- San Francisco, CAadviserinfo.sec.gov
- Office address
- 1070 MARYLAND STREET, SUITE 295, San Francisco, CA, 94107adviserinfo.sec.gov
- Business phone
- 415-363-3732adviserinfo.sec.gov
- Website
- m••••••••.bio
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 25, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $325Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- M•••••••• C•••••• M••••••••• L••• (Limited Partner), E; M•••••••• C•••••• H••••••• A•••••••• L•• (General Partner), NA; M•••••••• C•••••• H•••••••• L••• (Member), E
- business email
- media@monograph.biomonograph.biopublished by the subject
- business email
- info@monograph.biomonograph.biopublished by the subject
- business phone
- 415-363-3732adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- biotech, media
- Stages
- not stated or not yet read
- Geography
- uk
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 2
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| M•••••••• C•••••• P••••••• I•• L••• | Fund | 2024 adv first reported | Early deployment | $114M Nov 1, 2024 | 44 | unknown | unknown |
| M•••••••• C•••••• P••••••• I• L••• | Fund | unknown | Unknown | $104M Nov 1, 2024 | 52 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
18 current, 0 departed
J••••••• R••••
AssociateAssociate, MBBS, BSc
M••••••• H•
AssociateAssociate, BSc
O•••• M•••••
AssociateAssociate, PhD, BS
C•••••• Z•••
Board or advisoryAdvisor (in Portfolio), MPH, BM BCh, MA
J••••••• S•••
Investor relationsHead of Capital Formation, BA
C•••••• C•••
PartnerPartner, MBA, MA
C•••••• R••••• C•••
PartnerMember · since Mar 1, 2021
F••• C••••
PartnerPartner · since Apr 1, 2021
F••• C••••
PartnerPartner and Chairman, MD, DPhil
M••• M•••••••
PartnerPartner, MBA, MD
M•••••• A••••• L••••••
PartnerPartner · since May 1, 2023
T•• F••••••
PartnerPartner, DPhil, BS
D••••• S••••••
Platform and operationsChief Financial Officer, MSc
K••••••• N••••
Platform and operationsUS Operations Manager, BBA
R••••• K•••••
Platform and operationsUK Head of Operations, BA
F•••••• D•••
PrincipalPrincipal (Portfolio), BSc
J•••••• D•••••
PrincipalPrincipal (Portfolio), PhD, BS
M••••• G••••
PrincipalPrincipal, PhD, MSc, BSc
Investments on record
2 edges, 2 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| G••••• S••••••• t• A•••••• M•••••• f•• a••••• ••• m•••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| C• T••••••••• | portfolio listing | unknown | unknown | unknown | unknown | Sep 14, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
8 relationships from shared deals, counted for the whole firm
Asset Management Ventures, LLC 1 shared · one timeMenlo Ventures 1 shared · one timeArch Venture Partners 1 shared · one time · they led 1RA Capital Management, LP 1 shared · one timeCommodore Capital 1 shared · one timeTCGX 1 shared · one time · they led 1Blackstone Multi-Asset Investing 1 shared · one timeCanada Pension Plan Investment Board 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Sep 16, 2026C• T••••••••• no longer listed on M•••••••• C•••••• A•••••••• L•••'s portfolio pageRemoved from portfolio pagePortfolioInferenceC• T•••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Nov 1, 2024M•••••••• C•••••• P••••••• I•• L••• first reported on Form ADV by M•••••••• C•••••• A•••••••• L••• (Venture Capital Fund), GAV $114,410,264Fund first reported on Form ADVFundsFactM•••••••• C•••••• P••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- May 1, 2023M•••••• A••••• L•••••• joined Schedule A of M•••••••• C•••••• A•••••••• L••• as Partner
- Aug 16, 2021M•••••••• C•••••• Advisors first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 16, 2021M•••••••• C•••••• P••••••• I• L••• first reported on Form ADV by M•••••••• C•••••• Advisors (Venture Capital Fund), GAV $145,250,000Fund first reported on Form ADVFundsFactM•••••••• C•••••• P••••••• I• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $219M across 2 vehicles
Evidence
44 observations from 3 sources